| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.1 | 0.9 |
| Net income | -18.8 | -20.8 |
| EPS (diluted, $ a share) | $-0.30 | $-0.40 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -89.4% |
|---|
10-Q filed with the SEC, NASDAQ: OBIO. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Orchestra BioMed Holdings, Inc.: key numbers
- Share price
- $7.12Close, Nov 16
- Market cap
- $560M
- Shares outstanding
- 78.7MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Orchestra BioMed Holdings, Inc.
All →Orchestra BioMed Holdings 10% Owner Rtw Investments LP Buys $6M of Stock
Rtw Investments LP, 10% Owner, bought 1,200,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $6M in total on Nov 9, 2026. Shares held after the trade: 10,756,063 (+12.6%).
- Value
- $6M
- Shares
- 1,200,000
- Price
- $5.00
- Role
- 10% Owner
- Holding change
- +12.6%
- Trade date
- Nov 9, 2026
Orchestra BioMed Holdings Insider Eric S. Fain Buys $100K of Stock
Eric S. Fain bought 20,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $100K in total on Nov 9, 2026. Shares held after the trade: 119,630 (+20.1%).
- Value
- $100K
- Shares
- 20,000
- Price
- $5.00
- Holding change
- +20.1%
- Trade date
- Nov 9, 2026
Orchestra BioMed Holdings Insider David Pacitti Buys $100K of Stock
David Pacitti bought 20,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $100K in total on Nov 9, 2026. Shares held after the trade: 74,750 (+36.5%).
- Value
- $100K
- Shares
- 20,000
- Price
- $5.00
- Holding change
- +36.5%
- Trade date
- Nov 9, 2026
Orchestra BioMed Holdings Insider David P. Hochman Buys $25K of Stock
David P. Hochman bought 5,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $25K in total on Nov 9, 2026. Shares held after the trade: 437,916 (+1.2%).
- Value
- $25K
- Shares
- 5,000
- Price
- $5.00
- Holding change
- +1.2%
- Trade date
- Nov 9, 2026
Orchestra BioMed Holdings Capital Raise of $86.3M
Orchestra BioMed closed an underwritten public offering of 17,250,000 shares of common stock, which included the full exercise of the underwriters' over-allotment option. The offering was priced at $5.00 per share, generating gross proceeds of approximately $86.3 million. The company intends to use the funds to support its AVIM Therapy and Virtue SAB clinical programs, including the BACKBEAT global pivotal trial.
- Value
- $86.3M
- Counterparty
- Piper Sandler & Co.
Orchestra BioMed Holdings Insider Darren Sherman Sells $86.1K of Stock
Darren Sherman sold 15,000 shares of Orchestra BioMed Holdings, Inc. at $5.74 a share, worth $86.1K in total on Nov 2, 2026. Shares held after the trade: 1,104,402 (-1.3%).
- Value
- $86.1K
- Shares
- 15,000
- Price
- $5.74
- Holding change
- -1.3%
- Trade date
- Nov 2, 2026